5-MeO-DiPT hidroklorür
5-MeO-DiPT hidroklorür Fiyat aralığı: €23.50 ile €336.00 arası
Ürünlere geri dön
EPT fumarat (N-etil-N-propiltriptamin)
EPT fumarat (N-etil-N-propiltriptamin) Fiyat aralığı: €23.50 ile €336.00 arası

5-MeO-DMT serbest baz

5-MeO-DMT serbest baz özellikleri

Eş anlamlısı: 5-metoksi-N,N-dimetiltriptamin
CAS Numarası: 1019-45-0
Formül: 3-[2-(dimetilamino)etil]-5-metoksiindol
Mol Kütlesi: 218,3 g/mol
Saflık: >97%

Fiyat aralığı: €25.00 ile €700.00 arası

* Bu sayfadaki bilgiler özet niteliğindedir ve bu ilaçla ilgili mevcut tüm bilgileri kapsaması amaçlanmamıştır. Olası tüm kullanımları, talimatları, önlemleri, ilaç etkileşimlerini veya yan etkileri kapsamaz ve sağlık uzmanınızın uzmanlığının ve yargısının yerine geçmez.

5-MeO-DMT Freebase – Scientific Product Documentation

General Description

5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) freebase is a naturally occurring tryptamine with a potent psychoactive profile, found in various plants and animal secretions. In its freebase form, it offers superior volatility for certain research methods, making it valuable for pharmacological and neuroscience studies.


Teknik Özellikler

ParametreŞartname
Chemical FormulaC₁₃H₁₈N₂O
Molecular Weight218.29 g/mol
Saflık≥98% (HPLC-UV analyzed)
BiçimCrystalline/white powder
ÇözünürlükSoluble in organic solvents (ethanol, methanol, DMSO), limited in water
Erime noktası60-65°C (freebase)
İstikrarLight and oxygen sensitive; store under inert gas

Bilimsel Uygulamalar

1. Neuropharmacological Research

  • Serotonergic Action:  Potent 5-HT₁ₐ/₂ₐ agonist, relevant for studies of consciousness modulation.

  • EEG/fMRI studies:  Investigation of acute effects on brain wave patterns (e.g. gamma oscillations).

  • Neuroplasticity:  Possible BDNF-enhancing effects (in animal models).

2. Metabolic & Toxicological Studies

  • MAO-dependent metabolism:  Investigation of CYP2D6 and MAO-A degradation pathways.

  • Dose-dependent toxicity:  Determination of safety margins in cell cultures.

3. Comparative Pharmacology

  • Compared to DMT:  Higher potency but shorter duration of action (15-30 min when inhaled).

  • Compared to psilocybin:  Differences in receptor affinity and subjective effects.


Experimental Guidelines

Recommended Concentrations (In Vitro)

BaşvuruConcentration rangeÇözücü
Receptor binding assays1 nM – 10 µMPBS/DMSO (≤0.1%)
Cell culture experiments0.1 – 100 µMDMEM/FBS
Gas chromatography1 mg/ml (in methanol)Methanol (HPLC-grade)

Güvenlik protokolleri

  • Personal Protection:  Lab coat, nitrile gloves, safety glasses, FFP2 mask when handling powder.

  • Ventilation:  Always work under a fume cupboard when heating/evaporating.

  • Depolamak:  In amber vials, under argon, at -20°C (long term).


Stability & Storage

  • Raf ömrü:

    • Room temperature: <24 hours in solution.

    • 4°C: Stable for 3 days (under argon).

    • -20°C: >6 months (unchanged purity).

  • Degradation products:

    • Oxidation to indole derivatives (check by TLC/HPLC).


Analytical Certification

Each batch includes:

  1. HPLC-UV kromatogramı  (λ=280 nm, C18 column)

  2. GC-MS confirmation  (characteristic fragments: m/z 174, 160)

  3. Residual solvent analysis  (≤500 ppm)

  4. Water content  (Karl Fischer, <1%)


Legal Status (Netherlands)

  • Opium Act:  Not explicitly regulated, but possibly under analogous legislation.

  • Legislation:  A licence is required for scientific institutions (Appendix 2, Opium Act).

  • Export restrictions:  CITES listing (due to natural sources such as  Incilius alvarius ).


Sıkça Sorulan Sorular (SSS)

Q1: What is the difference between freebase and fumaric acid salt?
A: Freebase is more volatile (suitable for evaporation experiments), while fumaric acid salt is more stable in solutions.

Q2: How is 5-MeO-DFT detected in toxicology screens?
A: Identifiable by:

  • LC-MS/MS (precursor ion m/z 219 → product ion m/z 174)

  • Immunoassays: Cross-reactivity with some DMT tests (≤30%).

Q3: Are there any known pharmacokinetic interactions?
A:  Dangerous combinations:

  • MAO inhibitors (risk of serotonin syndrome).

  • SSRIs (reduced efficacy due to competition).

Q4: How to dispose of waste?
A: Inactivate with:

  1. Dilute hydrochloric acid (0.1M) for neutralization.

  2. Absorption with activated carbon.

  3. Dispose of as  hazardous chemical waste  (UN number: 3249).


References & Contact

Key publications:

  • Szára, S. (2007). “DMT and 5-MeO-DMT: Early human studies”.

  • Uthaug et al. (2021). “Psychopharmacology of 5-MeO-DMT”.


This product is intended solely for legitimate scientific research. Not for human or veterinary use. Users must comply with all local regulations.